GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Chase Sun Pharmaceutical Co Ltd (SZSE:300026) » Definitions » E10

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) E10 : ¥0.20 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Tianjin Chase Sun Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Tianjin Chase Sun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.20 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Tianjin Chase Sun Pharmaceutical Co was 11.50% per year. The lowest was 8.20% per year. And the median was 9.85% per year.

As of today (2024-06-19), Tianjin Chase Sun Pharmaceutical Co's current stock price is ¥3.21. Tianjin Chase Sun Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥0.20. Tianjin Chase Sun Pharmaceutical Co's Shiller PE Ratio of today is 16.05.

During the past 13 years, the highest Shiller PE Ratio of Tianjin Chase Sun Pharmaceutical Co was 47.87. The lowest was 16.05. And the median was 26.66.


Tianjin Chase Sun Pharmaceutical Co E10 Historical Data

The historical data trend for Tianjin Chase Sun Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Chase Sun Pharmaceutical Co E10 Chart

Tianjin Chase Sun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.16 0.18 0.19 -

Tianjin Chase Sun Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.20 0.20 - 0.20

Competitive Comparison of Tianjin Chase Sun Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Chase Sun Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Chase Sun Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Chase Sun Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Tianjin Chase Sun Pharmaceutical Co's Shiller PE Ratio falls into.



Tianjin Chase Sun Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tianjin Chase Sun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.02/115.2271*115.2271
=0.020

Current CPI (Mar. 2024) = 115.2271.

Tianjin Chase Sun Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201406 0.053 98.200 0.062
201409 0.043 98.900 0.050
201412 0.043 99.000 0.050
201503 0.033 99.900 0.038
201506 0.060 99.500 0.069
201509 0.067 100.500 0.077
201512 0.037 100.600 0.042
201603 0.040 102.200 0.045
201606 0.060 101.400 0.068
201609 0.055 102.400 0.062
201612 0.060 102.600 0.067
201703 0.040 103.200 0.045
201706 0.050 103.100 0.056
201709 0.060 104.100 0.066
201712 0.000 104.500 0.000
201803 0.060 105.300 0.066
201806 0.055 104.900 0.060
201809 0.040 106.600 0.043
201812 -0.080 106.500 -0.087
201903 0.060 107.700 0.064
201906 0.060 107.700 0.064
201909 0.060 109.800 0.063
201912 -0.030 111.200 -0.031
202003 0.040 112.300 0.041
202006 0.070 110.400 0.073
202009 0.080 111.700 0.083
202012 -0.010 111.500 -0.010
202103 0.060 112.662 0.061
202106 0.090 111.769 0.093
202109 0.060 112.215 0.062
202112 0.020 113.108 0.020
202203 0.080 114.335 0.081
202206 0.040 114.558 0.040
202209 0.040 115.339 0.040
202212 0.050 115.116 0.050
202303 0.060 115.116 0.060
202306 0.060 114.558 0.060
202309 0.050 115.339 0.050
202312 0.000 114.781 0.000
202403 0.020 115.227 0.020

Add all the adjusted EPS together and divide 10 will get our e10.


Tianjin Chase Sun Pharmaceutical Co  (SZSE:300026) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Tianjin Chase Sun Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3.21/0.2
=16.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Tianjin Chase Sun Pharmaceutical Co was 47.87. The lowest was 16.05. And the median was 26.66.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Tianjin Chase Sun Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Tianjin Chase Sun Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Business Description

Traded in Other Exchanges
N/A
Address
No. 20, Quanfa Road, Tianjin Wuqing Development Area, Tianjin, CHN, 301700
Tianjin Chase Sun Pharmaceutical Co Ltd is a high-tech medicine and health industry group. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet-based therapy.
Executives
Yao Xiao Qing Director
Chen Rui Qiang Executives
Li Chun Xu Executives
Lan Wu Jun Directors, Directors, and Executives
Zheng Dan Directors, executives
Zhang Kun Executives
Gao Guo Wei Executives
Shang Xiao Mei Securities Affairs Representative
Sun Zhang Hai Director
Wu Guang Ning Supervisors
Wang Long Executives
Liu Qiang Supervisors
Ceng Guo Zhuang Director
Su Bing Jun Directors, executives
Nie Wei Supervisors

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Headlines

No Headlines